e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
COPD: diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD: Exhaled NO concentration and its prognostic value for smoking patient
T. Pertseva, K. Gashynova, N. Efimova (Dnipropetrovsk, Ukraine)
Source:
Annual Congress 2010 - COPD: diagnosis
Session:
COPD: diagnosis
Session type:
Thematic Poster Session
Number:
4022
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Pertseva, K. Gashynova, N. Efimova (Dnipropetrovsk, Ukraine). COPD: Exhaled NO concentration and its prognostic value for smoking patient. Eur Respir J 2010; 36: Suppl. 54, 4022
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Smoking and exhaled NO concentration in patients with COPD
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010
Exhaled breath temperature as a possible early marker in smokers at risk for COPD (MARKO study)
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Exhaled 8-isoprostane as a possible prognostic marker in sarcoidosis
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009
Exacerbations after stepping down medication in children with well-controlled asthma: predictive value of spirometry and nitrite/nitrate concentration and pH in exhaled breath condensate
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Exhaled carbon monoxide as a marker of tobacco exposure: is it possible to use the same parameters in COPD patients?
Source: Eur Respir J 2006; 28: Suppl. 50, 389s
Year: 2006
Exhaled NO and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated smoking asthmatics
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Exhaled NO and exhaled breath condensate pH in the assessment of asthma control: a real-life study
Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma
Year: 2009
Decreased levels of bis-S-bimane in exhaled breath condensate of COPD
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
pH in exhaled breath condensate of patients with stable COPD: associations with disease severity and pulmonary function tests
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Diagnosing asthma and prognostic significance of eNO
Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management
Year: 2005
The effect of smoking and COPD on exhaled breath temperature
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010
Exhaled breath condensate pH for the identification of asymptomatic children at risk of asthma
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
Exhaled breath temperature in COPD patients
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012
Exhaled NO (eNO) as a screening test for asthma in children
Source: Eur Respir J 2002; 20: Suppl. 38, 509s
Year: 2002
The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers
Source: International Congress 2016 – Molecular pathways of smoking-induced diseases
Year: 2016
Exhaled breath condensate for evaluation of inflammation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Determine the relationship between fraction exhaled nitric oxide (FeNO) and mannitol challenge test in the diagnosis of suspected asthma patients.
Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept